Your browser doesn't support javascript.
loading
The effect of burosumab on intact and C-terminal FGF23 measurements.
Ashrafzadeh-Kian, Susan Louise; Ito, Nobuaki; Srivastava, Tarak; Garg, Uttam; Kato, Hajime; Algeciras-Schimnich, Alicia; Bornhorst, Joshua A.
Affiliation
  • Ashrafzadeh-Kian SL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Minnesota, Rochester, USA.
  • Ito N; Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo, Japan.
  • Srivastava T; Department of Pediatrics, Section of Nephrology, Children's Mercy Hospital, Missouri, Kansas City, USA.
  • Garg U; Department of Pathology & Laboratory Medicine, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Kato H; Division of Nephrology and Endocrinology, The University of Tokyo Hospital, Tokyo, Japan.
  • Algeciras-Schimnich A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Minnesota, Rochester, USA.
  • Bornhorst JA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Minnesota, Rochester, USA.
Clin Endocrinol (Oxf) ; 99(2): 152-157, 2023 08.
Article in En | MEDLINE | ID: mdl-36263608
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Familial Hypophosphatemic Rickets / Fibroblast Growth Factors Limits: Humans Language: En Journal: Clin Endocrinol (Oxf) Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Familial Hypophosphatemic Rickets / Fibroblast Growth Factors Limits: Humans Language: En Journal: Clin Endocrinol (Oxf) Year: 2023 Type: Article Affiliation country: United States